Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Lung transplantation (Tx) is an optional treatment for cystic fibrosis (CF) patients with end‐stage lung disease. The decision to place a patient on the Tx waiting list is frequently complex, difficult, and controversial. This study evaluated the current criteria for lung Tx and assessed additional parameters that may identify CF patients at high risk of death. Data were extracted from the medical records of 392 CF patients. Forty of these patients had a forced expiratory volume in 1 s (FEV1) less than 30% predicted, and nine of these 40 patients were transplanted. A comparison was performed between the survival of those transplanted (n = 9) and those not transplanted (n = 31), by means of Kaplan–Meier survival curves. The influence on survival of age, gender, nutritional status, sputum aspergillus, diabetes mellitus, recurrent hemoptysis, oxygen use, and the decline rate of FEV1, were investigated by means of univariate and multivariate analyses. The rate of decline of FEV1 was evaluated employing the linear regression model. CF patients with a FEV1 < 30% and who did not receive a lung transplant had survived longer than CF patients who did receive a lung transplant (median survival 7.33 vs. 3.49 yr, 5‐yr survival 73% vs. 29%). Two factors – rate of decline in FEV1 values and age < 15 yr – were found to influence the mortality rate, while the other parameters examined did not. Our results indicate that the current criterion of FEV1 < 30% predicted, alone is not sufficiently sensitive to predict the mortality rate in CF patients and time of referral for Tx, as many of these patients survive for long periods of time. Additional criteria to FEV1 < 30%, should include rapidly declining FEV1 values and age < 15 yr.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
Risk of death in cystic fibrosis patients with severely compromised lung function
Milla, C. E., & Warwick, W. J. (1998) · Chest · doi:10.1378/chest.113.5.1230 · Cited by 167
Cited by
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
“Patients who had FEV 1 o 30% of predicted had an increased early mortality only when Pa CO 2 was 4 50 mm Hg. 38 In a single-center study, Milla and Warwick 39 also found that the rate of decline was a better predictor of early mortality than FEV 1 alone.”
InfluentialOrens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
Recommendations on the use of exercise testing in clinical practice
Palange, P., Ward, S. A., Carlsen, K.-H., Casaburi, R., Gallagher, C. G., Gosselink, R., O'Donnell, D. E., Puente-Maestu, L., Schols, A. M., Singh, S., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00046906 · Cited by 718
Ramos, K. J., Smith, P. J., McKone, E. F., Pilewski, J. M., Lucy, A., Hempstead, S. E., Tallarico, E., Faro, A., Rosenbluth, D. B., Gray, A. L., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.03.002 · Cited by 227
Risk factors for death of patients with cystic fibrosis awaiting lung transplantation
Belkin, R. A., Henig, N. R., Singer, L. G., Chaparro, C., Rubenstein, R. C., Xie, S. X., Yee, J. Y., Kotloff, R. M., Lipson, D. A., & Bunin, G. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1369oc · Cited by 180
Metadata
- Authors
- Augarten, A., Akons, H., Aviram, M., Bentur, L., Blau, H., Picard, E., Rivlin, J., Miller, M. S., Katznelson, D., Szeinberg, A., Shmilovich, H., Paret, G., Laufer, J., & Yahav, Y.
- Venue
- Pediatric Transplantation
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 5
- Pages
- 339-342
- ISSN
- 1397-3142 (ISSN-L)
- 1399-3046
- OpenAlex
- W2028930678
- Cited by
- 65
- References
- 2
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. https://app.cochat.ai/papers/10.1034/j.1399-3046.2001.00019.x
- The paper
- Augarten, A., Akons, H., Aviram, M., Bentur, L., Blau, H., Picard, E., Rivlin, J., Miller, M. S., Katznelson, D., Szeinberg, A., Shmilovich, H., Paret, G., Laufer, J., & Yahav, Y. (2001). Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatric Transplantation. https://doi.org/10.1034/j.1399-3046.2001.00019.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.